Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at ...

Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking ...

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.

Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...

ORLANDO, Fla. (Ivanhoe Newswire) -Atrial fibrillation, called AFib, is the most common type of heart arrhythmia and experts say 12.1 million people in the U.S. will have AFib in 2030. While treatments ...

Wearable device data could predict New York Heart Association functional class similarly to clinical measures and 6-minute walk test. (HealthDay News) — For patients with atrial fibrillation, digoxin ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...

Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

INDIANAPOLIS (WISH) — Atrial fibrillation, called Afib, is the most common type of heart arrhythmia. Experts say 12.1 million people in the U.S. will have AFIB in 2030. While treatments like beta ...